Part 5/8:
The stigma surrounding addiction makes it challenging for both patients seeking help and providers aiming to offer suitable treatment. Providers receive less compensation for treating individuals with addictions compared to other conditions, such as depression. Additionally, the FDA's requirements for medication approval demand complete abstinence, a difficult benchmark that doesn’t apply to medications for other health conditions where reduction of symptoms is an acceptable outcome.